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There is a considerable amount of 
literature to indicate that epileptic children 
have more learning difficulties in school 
than age-matched controls or those with 
other chronic disabilities. This has been 
extensively documented by the senior 
author (Rodin 1968) and by Rutter et al. 
(1970), Stores (1978, 1981) and Bourgeois 
et al. (1983). Most authorities agree that 
the IQ of epileptic children who are not 
overtly brain-damaged lies in the average 
range, but there are indications that they 
tend to cluster towards the lower end and 
that their scores are slightly lower than 
those of their siblings (Needham et al. 
1969, Rodin 1978, Bourgeois et al. 1983). 
Although the findings may not reach 
statistical significance, it has also been 
observed, especially with the Wechsler 
Intelligence Scale, that the performance 
scores tend to be lower than the verbal 
scores (Angers 1958, de Moura Simoes 
1967, Wagner 1969). The most important 
factors contributing to lowered IQ scores 
were early age at onset of the illness, longer 
duration, persistence of seizures in spite of 
adequate treatment and possible CNS 
depressant effects from anticonvulsant 
medication (Freudenberg 1968, Hung 
1968, Rodin 1968, Tchicaloff and Gaillard 
1970, Vogt and Schlack 1974, Thompson 
and Trimble 1983). 
Most of the studies have a serious 
drawback, however, in that they present 
cross-sectional data and in many cases 
only one evaluation was done. Even when 
there were two evaluations the time 
between tests tends to be rather short, and 
since Patterson and Fonner (1928) and 
Barnes and Fetterman (1938) have pointed 
out that the IQ of epileptic children can 
fluctuate markedly, a single significant 
gain or loss cannot be taken as an 
indication of the patient’s permanent 
intellectual functions. Serial studies are 
quite rare, and a review of the literature has 
not yielded any data on long-term 
outcome. The most recent prospective 
study by Bourgeois et al. (1983) involved 
m an average follow-up of four years. Their 
study also used, in part, two different IQ 
measures, so possible differences between 8 
verbal and performance areas could not be W- 
evaluated. 2 
Since we had observed previously that A 
the Wechsler IQ results for young adult 3 e 
in the performance area) over five years 2 
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9 epileptic patients had shown a small but statistically significant decline (especially 
(Rodin 1968), and comparable data were 
lacking for children, this investigation was 
whether childhood-onset epilepsy has a 
deleterious influence on some mental z 
9 functions, as sampled by the Wechsler test 
and, if this were the case, to delineate some 
of the responsible factors. 
Material and method 




b . Michigan for children who were seen for 
multidisciplinary evaluation between the 
years 1958 and 1978 were reviewed. 
3 Patients who fulfilled the following criteria 
were then selected for the study: (1) definite 
E diagnosis of epilepsy, defined as a 
minimum of three epileptic seizures which 
a conformed to one of the types in the 
Q International Classification; (2) age at 
initial evaluation between five and 16 
years; (3) Wechsler IQ rather than 
* Stanford-Binet or other assessment of 
6 intellectual level at the initial evaluation; 
9 (4) one or more subsequent Wechsler IQ 
.- 8 tests, with the last one performed at least 
w" five years after the first. Patients who had 
who had an active concomitant CNS 
$ disorder were excluded from consideration. 
s This yielded 64 charts. The clinical and 
9 a laboratory information on the charts was 
then abstracted on forms for computer u 
G processing. Statistical evaluation was 
2 carried out through the Clinical Research 
.- c Center of the University of Michigan, as 
8 well as Wayne State University's AMDAHL 
470 V6, using the statistical package MIDAS 
c 1" developed by the University of Michigan. - B Paired t-tests were used to establish the 
* significance of changes between evalu- 
ations. Pearson product moment cor- 
relations and x2 tests with Yates' 
correction for small numbers were used 
when indicated to establish significance of 
relationships. All findings were evaluated 
at the alpha=O*05 level. 
The descriptive statistics of the patients 
are presented in Table I. It is noteworthy 
that the neurological examination was 
entirely normal for 70 per cent of the 
children. 25 per cent had 'soft signs', 
consisting mainly of mild difficulties with 
co-ordination, inattention or hyper- 
activity. Two patients had mild hemiparesis: 
it was right-sided in one and was probably 
related to prematurity; the other had 
developed a left-sided paralysis after the 
first seizure at 10 months of age and still 
had slight residual signs. One other patient 
had cerebral anoxia at birth and showed 
definite features of infantile hemiparesis, 















Bv the time of last follow-uD (mean 9 . 6  26 
years, range five to 33 years) 50 per cent of 
the patients had been seizure-free for at 
least two years. The anticonvulsant 
regimens had become less complex because 
the mean number of anticonvulsants per 
patient had decreased from 2 . 3  to 1 .6 .  
Four patients' anticonvulsants had been 
discontinued for between one and six 
years. EEG background slowing had 
improved slightly and the EEG seizure 
discharges had lessened significantly 
(p<O. 005). 
These generally positive developments, 
however, were not fully reflected in the IQ 
measurements. When the total group was 
compared for Verbal, Performance and 
Full-scale IQ, there was a slight but not 
statistically significant decrease between 
the first and last evaluations on all three 
measures (VIQ 9 3 . 2  vs. 90.3;  PIQ 9 2 . 5  vs. 
91.4;  FSIQ 9 1 . 6  vs. 90.2)  (Table 11). The 
sample was split into remitted and 
unremitted (N = 32 vs. N = 31). One patient 
was eliminated from consideration because 
the history of current seizure frequency 
was unreliable. The findings are shown in 
Tables I11 and IV. Patients who continued 
to have seizures had small losses of 
function in all measured areas. It was 
statistically significant for the PIQ and 
vocabulary, as well as picture arrangement 
subtests. The remitted group had a slight 
increase in function for PIQ and FSIQ, as 
well as  on five subtests. There was no 
change in three of the subtests and a slight 
decrease in another three. The VIQ had also 
decreased slightly, but not to the same 
extent as in the unremitted group. None of 
the changes in the remitted group was 
sufficiently large or consistent to  reach 
statistical significance. 
It seemed possible that the decreased 
scores of patients with active seizures 
might be due to etiological factors also 
responsible for the epilepsy, so an 
additional analysis was carried out of those 
for whom there was no evidence of 
prenatal or perinatal difficulties, head 
injury, cerebral infection or other potential 
external cause, and who had entirely 
normal neurological examinations. There 
were 33 such patients, 70 per cent of whom 
were female. There was a family history of 
epilepsy in 33 per cent. The same trend of 
decreased scores for the 15 patients who 
still had seizures within the Drevious two 
TABLE I 














1 type only 
2 types 
3 types 





Other external causes 
Family history of epilepsy 





















Seizures in remission 







4 6 . 2  
8 12.5 
4 6 . 2  
5 7 . 8  
50 78.1 
13 20.3 
1 1 . 5  
1 1 . 5  
None Questionable Definite 
N %  N % N %  
41 64.0 19 29.6 4 12.5 
56 87.5 8 12.5 ~ 
60 93.7 4 6 . 2  - 













5 7 . 8  
33 58.9 
22 39 .3  
1 1 . 8  
8 12.5 
Mean S D  Range 
Age 6 r s )  10.0 3 . 1  5-16 
Duration of epilepsy (yrs) 3 . 7  3 . 4  <1-11.7 
Frequency of seizures 
Tonic-clonic 4/yr 2-6/yr <I /yr ->l /wk 
All others I-2/mth Z/yr-l/wk < l / y r - > l / w k  
Anticonvulsant regimens and dosages 
Phenytoin 47 205 106.8 32-500 40 266 102.7 60-575 
Initial F0ll0 W-UP 
N Mean S D  Range N Mean S D  Range 
Phenobarbital 41 63 28.3 15-120 25 88 20 .8  30-200 
Primidone 14 612 325.5 125-1000 8 768 107.4 150-1000 
Carbamazepine 5 560 219.0 200-800 3 866 205.8 600-1200 
Valproate 10 1050 752.7 500-2500 9 1388 875.0 500-2500 
Ethosuximide 17 741 310.8 100-1250 12 841 322.7 100-1500 
Others 17 I I  
Not on anticonvulsants 8 2 .8yrs (<1-6yrs )  6 3 .1yrs (<1-7yrs )  





*Ill-defined or poorly described episodic symptoms in addition to at least one of the above. 27 
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Initial vs. final IQ values of total group (N= 64) 














































3 . 0  
2 .5  
3 . 0  
2 .8  
3 . 9  
3 . 6  
2 . 7  
4.4 
4 .8  
4: 8 
















Initial vs. final IQ values of non-remitted patients (N=31) 



















8 .5 /8 .3  
8 .617 .0  




9 .511 .1  
8,518.3 
8.918.2 


















2 . 9  
2 . 6  
3 . 4  
2 .8  
2 .8  
3 . 8  
2 . 6  
4 . 2  
2 . 6  
4 . 5  
















Initial vs. final IQ values of remitted patients (N=32) 
~ ~ ~ ~ ~ _ _ _ _ _  ~~ 


















8 . 3 / 8 . 6  
8 . 0 j 8 . 0  
8 .3 /8 .3  





8 . 9 1  10.6 
10.21 10.1 
10.3/9.0 
-1 .0  11.6 NS 
+2.0 10.2 NS 
i l . 0  10.2 NS 
+0 .3  2 .9  NS 
0 2 .5  NS 
0 2 . 4  NS 
-0.8 2 . 8  NS 
0 4 . 7  NS 
+0.9 3 . 4  NS 
-0.1 2 . 9  NS 
+0.7 4 . 4  NS 
+1 .6  6 .3  NS 
+ ] . I  5.0 NS 
-1.3 8 . 5  NS 
years was again observed (VIQ 93.7 vs. 
91.0; PIQ 94.2 vs. 90.9; FSIQ 93.4 vs. 
90.4). The differences were not statistically 
significant, again probably due to the small 
numbers involved. A rise in PIQ was 
observed for the 18 patients who were in 
remission (97.8 vs. 99.7), but that also was 
not of statistical significance; VIQ and FSIQ 
were unchanged. 
Since scaled scores carry an age- 
correction factor, the decrease in IQ points 
could have come about either through 
actual loss of previously acquired abilities 
or slowed mental growth, thus creating a 
discrepancy between chronological and 
mental age. A decrease in the raw scores 
suggests a degenerative process, while an 
insufficient increase in raw scores argues in 
favor of slowed development. Inasmuch as 
raw scores of the WAIS and WISC cannot be 
directly compared, this aspect of the 
investigation was limited to the 33 patients 
who had at least two WISc evaluations. It 
was apparent that the raw scores had 
increased, even for the patients with 
decreased scaled scores, and the reported 
IQ differences therefore were due to slowed 
mental growth. 
While these findings established direc- 
tion of change, they masked the magnitude 
because of fluctuations in test-retest 
scores. A decrease of 10 or more points in 
the verbal area had occurred for 19 
patients and in the performance area for 13 
of the total group. An increase of the same 
magnitude was observed in the verbal area 
for nine and the performance area for 10 
patients. These fluctuations occurred at 
any IQ level. The maximum increase in VIQ 
was 27 points (92 to 119) and for PIQ 26 
points (93 to 119). The maximum decreases 
were 3 1 points for VIQ ( 1  14 to 83) and 29 
points for PIQ (114 to 85). Verbal and 
performance changes did not necessarily 
occur in the same direction. The patient 
who had the largest gain in the verbal area 
had a one-point loss in Performance IQ, 
while the patient who had gained 26 points 
on Performance IQ had gained only 11 
points on the verbal portion (90 to  101). 
The patient who had lost 31 points on the 
verbal scale had lost 21 on performance 
(100 to 79), and the patient who had a 
performance loss of 29 points had a verbal 
drop of 18 points (105 to 87). 
The relationship between significant loss 
or  gain of IQ points (defined as a difference 
of at least 10 points between first and last 
evaluations) and clinical state is shown in 
Tables V and VI. It can be seen that, in 
general, a minimum gain of 10 points 
occurred in the performance area only 
when the patient was in remission. 
However, clinical remission was not 
necessarily associated with PIQ gain, and 
occasionally there were even considerable 
losses, as will be discussed later. VIQ 
changes of the magnitude under discussion 
occurred regardless of clinical state. 
Test-retest findings showed considerable 
fluctuations for the 28 individuals who had 
at least three follow-up evaluations. A 
consistent downhill course leading to a 
minimum 10-point loss was observed for 
five (17.8 per cent) in VIQ, for seven in 
PIQ (25 per cent) and for eight in FSIQ (28 * 5 
per cent). A consistent rise of the same 
magnitude occurred for three in VIQ (10 * 7 
per cent), one in PIQ (3 * 5 per cent) and five 
in FSIQ (17.8 per cent). 
An attempt to define factors from the 
first evaluation that would predict IQ gain 
or loss was largely unsuccessful. There 
were no signficant relationships between 
age, sex, presence or absence of etiological 
factors by history, neurological examin- 
ation, EEG observations, seizure type, 
seizure frequency or duration of seizure 
disorder and VIQ, PIQ or FSIQ. The only 
significant relationship was with higher 
initial Verbal IQ (VIQ 98 vs. 88, p<O-Ol), 
and the seizure disorder had started at an 
earlier age in the patients who had lost 10 
or more PIQ points (51 months vs. 100 
months, p<O.O2). Since there were no 
other significant relationships, regression 
or discriminant function analysis could not 
be carried out. 
The data on anticonvulsant levels are 
incomplete because determinations had 
been performed only during the past 10 
years; also, since the study deals with 
retrospective information, blood samples 
had been obtained only infrequently on the 
day of psychological evaluation. This was 
the case in 31 instances for phenytoin, 29 
for phenobarbital, eight for valproate, 
seven for ethosuximide, six for primidone 
and four for carbamazepine. The mean 
levels and ranges are shown in Table VII. 
Because of small sample size the IQ 












Relationships of minimum 10-point gain or loss for 
VIQ 
Gain Loss Total 
Non-remitted 3 9 12 
Remitted 6 10 16 
Total 9 19 28 
x*=O.O8, NS 
TABLE VI 
Relationships of minimum 10-point gain or loss for 
P1Q 
Gain Loss Total 
Non-remitted 
Remitted 
1 9 10 
9 4 13 
Total 10 13 23 
~2’6.0, p<0.02 
TABLE VII 
Anticonvulsant levels at time of psychological testing 
(Pg/ml) 
~~ 
N Mean S D  Range 
Phenytoin 31 12:3 7 . 2  5.2- 29.8 
Phenobarbital 29 20.5 11.2 5.6- 49.3 
Primidone 6 10.4 4 .5  2.8- 14.7 
Carbamazepine 4 4 .6  1 . 5  3.3- 6 . 8  
Valproate 8 43.9 2.1 16.2- 78.9 
Ethosuximide 7 47.8 3.8 56.0-105.3 
TABLE VIII 
Significant correlations of phenobarbital level with 
IQ measures (N=29) 
r P 
Performance IQ -0.46 10.01 
Full-scale IQ -0.38 <0.03 
Similarities -0.39 <0.03 
Block design -0 .37 10 .04  
Digit symbol -0.45 <0.01 
phenytoin and phenobarbital. N o  signifi- 
cant correlations were observed between 
phenytoin levels and IQ measures (VIQ r 
-0.07, PIQ r -0.19, FSIQ r -0.01). 
Phenytoin levels which would be 
considered in the ‘toxic’ range had 
occurred only twice (26.8 and29*8pg/ml). 
The statistically significant relationship 
between phenobarbital levels and IQ 
measures are shown in Table VIII. The 
correlation was not significant for the VIQ 
( r  -0- 16). When the sample was split into 
groups of 14 patients whose phenobarbital 
levels had been less than 20pg/ml versus 
those whose levels had been greater, the 
meanPIQs were90*7vs.78.7(p<O’02). 10 
patients had had more than one 
determination of phenobarbital level in 
conjunction with IQ testing, but a marked 
fluctuation in levels had occurred only 
once, and phenobarbital levels above 
40pg/ml had been encountered in only two 
instances (41.1 and 49*3pg/ml). 
Discussion 
The results of this investigation confirm 
that IQ levels of epileptic children tend to 
be slightly below the mean, and that they 
can fluctuate markedly on retests in a 
positive as well as negative direction. 
Therefore a single evaluation can not be 
used to establish a long-term prognosis 
and it can be misleading, especially if 
anticonvulsant levels are not measured 
close to the time of testing. Elevated levels, 
especially of phenobarbital and occasion- 
ally of phenytoin, may not result in 
obvious clinical toxicity and therefore can 
be missed unless specifically tested for. Yet 
they can interfere significantly with 
cognitive abilities, especially in the areas of 
new learning. 
Phenobarbital but not phenytoin levels 
were significantly inversely correlated with 
IQ, probably because phenobarbital levels 
had been significantly higher (p<O * 005), 
which resulted from the assumption that 
levels up to 40pg/ml are within the 
‘therapeutic’ range (Pippenger et al. 1978, 
Kutt and Paris-Kutt 1982). The data 
presented here, as well as those of 
Reynolds and Travers (1974), Bourgeois 
et al. (1983), and Reynolds (1983) suggest 
that this is not necessarilyjustified and that 
revision of the upper limit to between 20 - -  
and 25pg/ml m a i b e  advisable. 
A steady rise in IQ was observed mainly 
for patients whose seizures were con- 
trolled, while a drop in IQ occurred mainly 
among those whose seizures were not 
controlled. This agrees with previous 
findings for adults (Rodin 1968, Seidenberg 
et al. 1981) and for children (Bourgeois 
et al. 1983). The precise percentage of 
patients with major IQ loss (10 points or 
more) depends not only on the 
composition of the sample, i.e. how many 
patients still have seizures or are in 
remission, but also on length of follow-up. 
11 * 7 per cent of the patients in Bourgeois 
and colleagues’ study had deteriorated 
intellectually, compared to 28 per cent in 
our sample. This discrepancy may well be 
due to longer follow-up of our cases, and 
the fact that 25 of 63 (39.6 per cent) still 
had seizures within the last year of follow- 
up. In the Bourgeois eta/. study only 13 of 
72 (1 8 per cent) were regarded as ‘difficult 
to control’, but the term was not defined 
further. They also gave the impression that 
a discriminant function formula based on 
age at onset of seizures and frequency of 
toxic levels of anticonvulsants allowed 
accurate classification of 71 per cent of 
their patients with regard to prognosis for 
intellect. However, careful reading of the 
data showed not only that the ‘difficult to 
control’ group had a similar degree of IQ 
decline to the ‘toxic’ group, as was pointed 
out by Shafer (1984), but also that the 71 
per cent figure is clinically not very 
meaningful. When one calculates the 
percentages presented in the paper, the 
formula classified correctly 93.6 per cent 
of the patients whose IQ remained within 
10 points, but only 42 8 per cent whose IQ 
had decreased and none whose IQ had 
increased. 
Neither Bourgeois and colleagues’ nor 
our study yielded a reliable set of criteria 
which would allow an accurate prognosis 
of patients’ future intellectual functions at 
the time of first evaluation. Prognostication 
improves when one follows the course of 
the illness. Early onset of seizures tends to 
be associated with some intellectual 
decline, as can persistently high levels of 
sedative anticonvulsant drugs, but these 
factors do not fully explain the clinical 
picture in all instances. We had patients in 
our series whose seizures were in 
remission. who were either off anti- 
convulsants or carried low levels, yet had 
decreased intellectual abilities. 
We found no factors which could be 
regarded as etiological for the patient’s 
epilepsy and which might have caused a 
cerebral degenerative process. This raises 
the question of whether there is a subgroup 
of epileptic children whose seizures and 
EEG manifestations improve, but the as yet 
unknown cerebral metabolic disturbance 
which predisposes to epileptic seizures 
persists and reasserts itself later in life. 
Neurologists who see mainly adults are 
familiar with patients who had ‘outgrown’ 
their seizures in childhood and are seen 
because of recurrence decades later. One 
wonders, therefore, whether IQ measure- 
ments could have predictive value, in that a 
failure for IQ to rise when seizures cease 
and anticonvulsants are withdrawn may 
have negative prognostic implications. 
This will require further long-term studies, 
as will the question of the relationship of 
anticonvulsants to specific aspects of 
mental function. Since patients with 
intractable seizures tend to receive higher 
doses of anticonvulsant medications, 
cumulative effects could be expected. 
Nevertheless, there is a suggestion in our 
results that the Wechsler subtests may 
make it possible to distinguish between 
changes resulting from epilepsy and those 
due to phenobarbital. Digit symbol, block 
designs and similarities were significantly 
related to phenobarbital levels, while 
vocabulary and picture arrangement 
appear to have been influenced by 
continued seizures. These findings, how- 
ever, should be regarded as tentative. 
Studies of this type require a long-term 
commitment but they can be facilitated if 
physicians recognize the problem, and if 
IQ testing of the patient who has just 
experienced an epileptic seizure were to  be 
carried out as routinely as the EEG is. This 
would provide a baseline against which 
future progress or lack of it can be 
measured. A test which allows separate 
assessment of verbal and performance 
functions is preferable to one which gives 
only global data. The verbal and 
performance areas of IQ are only 
moderately correlated for children with 
epilepsy (r  0 * 44 for first and 0 . 6  1 at last 
evaluations) and they need not necessarily 













extent during the course of the illness. 
Periodic IQ re-evaluation, combined with 
determinations of anticonvulsant levels, 
would then establish the direction of a 
child’s cognitive development. Slowed 
mental growth then could be detected early 
and remedial action taken whenever 
possible. 
The long-term social prognosis, in 
contrast to the medical prognosis, is not 
good for the majority of patients with 
childhood epilepsy, as the studies by 
Sillanpaa (1973) and Harrison and Taylor 
(1976) have shown. They tend to end up in 
the lower socio-economic brackets of 
society, which in all probability is due to 
decreased scholastic achievements which 
did not prepare them adequately for 
competitive employment. It needs to  be 
recognized, therefore, that treatment of 
SUMMARY 
childhood epilepsy involves more than the 
seizures themselves. The physician has to 
be aware of the potentially fluctuating 
nature of the patient’s cognitive abilities 
and this should be integrated in the total 
treatment approach. 
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The intellectual functions of 64 epileptic patients who had had an initial evaluation between five and 16 years 
of age, including the WISC, were re-evaluated after a period of at least five years. In general the seizure 
states had improved, and 50 per cent were in remission for between two and eight years. All but four were 
still taking at least one anticonvulsant drug. WISC IQ esti,mates showed a slight decrease. Verbal and 
performance areas could be differentially affected, and a gain in one could be offset by a loss in the other, so 
the Full-scale IQ might not be a reliable measure of day-to-day performance. Those whose seizures remained 
uncontrolled had a statistically significant decrease in performance IQ, whereas in general it was stable or  
increased for patients in remission. There was evidence that decreased IQ indicated slower mental growth 
rather than loss of previously acquired function. Phenobarbital but not phenytoin levels were inversely 
correlated with IQ, suggesting that the upper limit of the ‘therapeutic range’ of phenobarbital may already be 
toxic with regard to learning abilities. To  optimize an epileptic child‘s functioning in school and to  prevent 
long-term intellectual problems, it is advisable that IQ testing should be part of the routine initial evaluation, 
and that drug levels should be checked at  regular intervals. 
RESUMB 
Les fonctions intellectuelles de 64 Cpileptiques dont I’intelligence avait Ctt CvaluCe entre cinq et 16 ans, 
notamment par le WISC, ont  t t t  remesurtes aprbs une ptriode d’au moins cinq ans. En gtntral I’ttat des 
crises s’ttait amtliort et 50 pour cent des sujets btaient en rtmission pour des ptriodes allant de deux L huit 
ans. Tous les sujets sauf quatre prenaient encore une mtdication anticomitiale. Les QI au WISC montraient 
une Itgbre perte. Les tchelles verbale et performance pouvaient Etre modifites de faqon difftrente et un gain 
dans l’une des tchelles pouvait Etre compenst par une perte dans I’autre, si bien que la pleine tchelle de QI 
pourrait ne pas ktre une mesure fiable des performances journalibres. Les sujets dont les crises demeuraient 
non contrbldes prtsentaient une baisse statistiquement significative a I’tchelle de performance, alors que cette 
tchelle Ctait en gtntral stable ou en gain pour les sujets en rkmission. Des signes indiquaient que la baisse de 
QI ttait davantage lite 
anttrieurement acquises. Les taux de phtnobarbital mais non de phtnytoine Ctaient inversement corrtlts au 
QI, suggCrant que la limite suptrieure de “I’ttendue thtrapeutique” du phtnobarbital peut deja &tre toxique 
en ce qui concerne les aptitudes d’apprentissage. Pour optimiser I’activitt scolaire d’un enfant tpileptique et 
pour prtvenir des problkmes intellectuels i long terme, il est souhaitable que des mesures de QI fassent partie 
des &valuations initiales de routine et que les taux de mCdication soient contrblts a intervalles reguliers. 
ZUSAMMENFASSUNG 
64 Patienten mit Epilepsie, die zwischen funf und 16 Jahren erstmals untersucht und beurteilt- 
einschlieRlich WISC-worden waren, wurden nach mindestens fiinf Jahren nachuntersucht. Im allgemeinen 
hatte sich das Anfallsleiden gebessert und 50 Prozent waren seit zwei bis acht Jahren in der Remission. Alle, 
auRer vier Patienten, nahmen noch mindestens ein Antikonvulsivum. WISC IQ-Schatzungen zeigten eine 
leichte Verschlechterung. Verbale-und Leistungs- Bereiche konnten unterschiedlich betroffen sein und eine 
Verbesserung in einem Bereich konnte durch eine Verschlechterung in dem anderen relativiert werden, so ist 
der Gesamt-IQ nicht unbedingt ein verlaRliches MaR fur die tagliche Leistung. Die Patienten mit 
unkontrolliertem Anfallsleiden zeigten eine statistisch signifikante Verschlechterung des Leistungs-IQ, 
wahrend er bei Patienten in der Remission im allgemeinen stabil war oder besser wurde. Es fanden sich 
Hinweise dafiir, daR ein abfallender IQ eine verlangsamte geistige Entwicklung anzeigte und nicht einen 
un ralentissement de la croissance mentale qu’a une perte des fonctions 
Verlust von zuvor erworbenen Funktionen. Phenobarbital, jedoch nicht Phenytoinspiegel korrelierten 
umgekehrt mit dem IQ, was vermuten lafit, dafi der obere therapeutische Bereich von Phenobarbital schon 
im Hinblick auf die Lernfahigkeit toxisch sein kann. Um die Schulleistungen eines Kindes mit Epilepsie zu 
verbessern und um spatere intellektuelle Probleme zu vermeiden, ist es ratsam, IQ-Testungen als Teil der 
routinemanigen Erstbeurteilung durchzufiihren und in regelmafiigen Abstanden Medikamentenspiegel zu 
kontrollieren. 
RESUMEN 
Las funciones intelectuales de 64 pacientes epilkpticos que habian pasado una primera evaluaci6n entre 10s 
cinco y 10s 16 aiios de edad, incluyendo el WISC, fueron reevaluados desputs de un period0 de a1 menos 
cinco afios. En general la incidencia de ataques habia mejorado y el 50 por ciento se hallaban en remisi6n 
de dos a ocho afios. Todos except0 cuatro tomaban todavia un firmaco anticomicial El CI en el WISC 
mostraba un ligero descenso. Las ireas verbales y de manipulacidn podian afectase diferentemente, de forma 
que la mejoria en un campo podia ser desvirtuada por un descenso en el otro, por lo que la escala global de 
CI podia no ser una medici6n fidedigna de la realizacibn dia a dia. Aquellos cuyas convulsiones permanecian 
sin control tenian una disminucibn estadisticamente significativa en el CI manipulativo, mientras que en 
general permanecia estable o aumentaba en 10s pacientes en remisi6n. Esto evidencia que el descenso en el CI 
indicaba un crecimiento mental mas lento, mis  bien que una ptrdida de una funci6n previamente 
conseguida. Los niveles de fenobarbital, per0 no 10s de fenitoina, estaban en correlaci6n inversa con el CI, 
lo que sugiere que el limite superior del margen teraptutico del fenobarbital puede ya ser t6xico con respecto 
a las capacidades de aprendizaje. Para optimizar el que un niiio epiltptico vaya bien en la escuela y para 
prevenir problemas intelectuales a largo plazo, se aconseja que la medici6n del CI forme parte de la rutina de 
exploraci6n inicial y que la determinaci6n de 10s niveles en sangre de 10s firmacos se haga a intervalos 
regulares. 
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